Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint-Reference-Cited by-同舟云学术

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint

Published:2019-12 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Voets Erik,Paradé Marc,Lutje Hulsik David,Spijkers Sanne,Janssen Wout,Rens Joost,Reinieren-Beeren Inge,van den Tillaart Gilbert,van Duijnhoven Sander,Driessen Lilian,Habraken Maurice,van Zandvoort Peter,Kreijtz Joost,Vink Paul,van Elsas Andrea^ORCID,van Eenennaam Hans

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0772-0.pdf

Reference51 articles.

1. Matlung HL, Szilagyi K, Barclay NA, van den Berg TK. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer. Immunol Rev. 2017;276(1):145–64.

2. Janssen WJ, McPhillips KA, Dickinson MG, Linderman DJ, Morimoto K, Xiao YQ, et al. Surfactant proteins a and D suppress alveolar macrophage phagocytosis via interaction with SIRPα. Am J Respir Crit Care Med. 2008;178(2):158–67.

3. Jiang P, Lagenaur CF, Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem. 1999;274(2):559–62.

4. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science. 2000;288(5473):2051–4.

5. Yamao T, Noguchi T, Takeuchi O, Nishiyama U, Morita H, Hagiwara T, et al. Negative regulation of platelet clearance and of the macrophage phagocytic response by the Transmembrane glycoprotein SHPS-1. J Biol Chem. 2002;277(42):39833–9.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pan-allelic human SIRPα-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response;Antibody Therapeutics;2024-07

2. Blockade of SIRPα-CD47 axis by anti-SIRPα antibody enhances anti-tumor activity of DXd antibody-drug conjugates;PLOS ONE;2024-06-06

3. A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma;Current Oncology;2024-06-01

4. Immune checkpoint inhibitors: breakthroughs in cancer treatment;Cancer Biology & Medicine;2024-05-24

5. Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation;Cells;2024-05-11